Top Markets
Coin of the day
Photocure ASA Photocure ASA

Photocure ASA

PHO
Clasificación en acciones #19791
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
Precio por acción
$5.66
Última sincronización: 2026-08-25
Capitalización bursátil
$150.59M
Cambio (1 día)
0.00%
Cambio (1 año)
-7.22%
País
NO
Comercio Photocure ASA (PHO)

Categoría

Historial de rendimiento por dividendo de Photocure ASA (PHO)
Rendimiento por dividendo (TTM) de Photocure ASA (símbolo bursátil: PHO) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Photocure ASA (PHO) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH